Voglimet GM2 Tablet is an anti-diabetic combination medicine that contains Voglibose, Metformin, and Glimepiride. It helps control high blood sugar levels in adults with type 2 diabetes mellitus when diet and exercise alone are insufficient.

• Voglibose delays the absorption of glucose from the intestine, preventing sudden spikes in blood sugar after meals.

• Metformin reduces glucose production in the liver and improves insulin sensitivity.

• Glimepiride stimulates the pancreas to release more insulin.

Uses:

• Management of type 2 diabetes to maintain normal blood sugar levels

• Prevention of complications related to uncontrolled diabetes, such as kidney damage, nerve problems, vision issues, and heart disease

• Can be used as part of combination therapy with diet and exercise for better glycemic control

Side Effects:
Voglimet GM2 is effective but may cause:

• Common: Gas, bloating, diarrhea, abdominal discomfort, nausea

• Occasional: Headache, dizziness, metallic taste, mild weight gain

• Rare but serious: Low blood sugar (hypoglycemia) with symptoms like sweating, shakiness, confusion; lactic acidosis (very rare, linked to metformin); severe allergic reactions

Precautions:
Take with meals to reduce stomach upset. Monitor blood sugar regularly. Avoid alcohol. Not suitable for patients with severe kidney or liver disease. Use only under medical supervision.